Literature DB >> 30354238

V-ATPase (Vacuolar ATPase) Activity Required for ABCA1 (ATP-Binding Cassette Protein A1)-Mediated Cholesterol Efflux.

Shuhui Wang Lorkowski1, Gregory Brubaker1, Kailash Gulshan1, Jonathan D Smith1,2.   

Abstract

Objective- We have shown that ABCA1 (ATP-binding cassette protein A1) mediates unfolding of the apoA1 (apolipoprotein A1) N-terminal helical hairpin during apoA1 lipidation. Others have shown that an acidic pH exposes the hydrophobic surface of apoA1. We postulated that the V-ATPase (vacuolar ATPase) proton pump facilitates apoA1 unfolding and promotes ABCA1-mediated cholesterol efflux. Approach and Results- We found that V-ATPase inhibitors dose-dependently decreased ABCA1-mediated cholesterol efflux to apoA1 in baby hamster kidney cells and RAW264.7 cells; and similarly, siRNA knockdown of ATP6V0C inhibited ABCA1-mediated cholesterol efflux to apoA1 in RAW264.7 cells. Although ABCA1 expression did not alter total cellular levels of V-ATPase, ABCA1 increased the cell surface levels of the V0A1 and V1E1 subunits of V-ATPase. We generated a fluorescein isothiocyanate/Alexa647 double-labeled fluorescent ratiometric apoA1 pH indicator whose fluorescein isothiocyanate/Alexa647 emission ratio decreased as the pH drops. We found that ABCA1 induction in baby hamster kidney cells led to acidification of the cell-associated apoA1 pH indicator, compared with control cells without ABCA1 expression. The V-ATPase inhibitor bafilomycin A1 dose-dependently inhibited the apoA1 pH shift in ABCA1-expressing cells, without affecting the levels of cell-associated apoA1. However, we were not able to detect ABCA1-mediated extracellular proton release. We showed that acidic pH facilitated apoA1 unfolding, apoA1 solubilization of phosphatidycholine:phosphatidyserine liposomes, and increased lipid fluidity of these liposomes. Conclusions- Our results support a model that ABCA1 recruits V-ATPase to the plasma membrane where V-ATPase mediates apoA1 acidification and membrane remodeling that promote apoA1 unfolding and ABCA1-mediated HDL (high-density lipoprotein) biogenesis and lipid efflux.

Entities:  

Keywords:  ATP-binding cassette transporters; apolipoproteins; cell membrane; cholesterol, HDL; vacuolar proton-translocating ATPases

Mesh:

Substances:

Year:  2018        PMID: 30354238      PMCID: PMC6209108          DOI: 10.1161/ATVBAHA.118.311814

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  41 in total

1.  Cellular localization and trafficking of the human ABCA1 transporter.

Authors:  E B Neufeld; A T Remaley; S J Demosky; J A Stonik; A M Cooney; M Comly; N K Dwyer; M Zhang; J Blanchette-Mackie; S Santamarina-Fojo; H B Brewer
Journal:  J Biol Chem       Date:  2001-05-10       Impact factor: 5.157

2.  Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3/4 elements.

Authors:  Wilfried Le Goff; Ping Zheng; Gregory Brubaker; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-22       Impact factor: 8.311

3.  ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions.

Authors:  Ashley M Vaughan; John F Oram
Journal:  J Lipid Res       Date:  2003-04-16       Impact factor: 5.922

4.  The ABC transporter PGP-2 from Caenorhabditis elegans is expressed in the sensory neuron pair AWA and contributes to lysosome formation and lipid storage within the intestine.

Authors:  Frank Nunes; Marc Wolf; Jörg Hartmann; Rüdiger J Paul
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

Review 5.  ABCA1 and nascent HDL biogenesis.

Authors:  Shuhui Wang; Jonathan D Smith
Journal:  Biofactors       Date:  2014-10-30       Impact factor: 6.113

6.  The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis.

Authors:  Agnes Roczniak-Ferguson; Constance S Petit; Florian Froehlich; Sharon Qian; Jennifer Ky; Brittany Angarola; Tobias C Walther; Shawn M Ferguson
Journal:  Sci Signal       Date:  2012-06-12       Impact factor: 8.192

7.  ABCA1 mediates unfolding of apolipoprotein AI N terminus on the cell surface before lipidation and release of nascent high-density lipoprotein.

Authors:  Shuhui Wang; Kailash Gulshan; Gregory Brubaker; Stanley L Hazen; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

8.  The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.

Authors:  Edward B Neufeld; John A Stonik; Stephen J Demosky; Catherine L Knapper; Christian A Combs; Adele Cooney; Marcella Comly; Nancy Dwyer; Joan Blanchette-Mackie; Alan T Remaley; Silvia Santamarina-Fojo; H Bryan Brewer
Journal:  J Biol Chem       Date:  2004-01-27       Impact factor: 5.157

9.  Conformational change of apolipoprotein A-I and HDL formation from model membranes under intracellular acidic conditions.

Authors:  Masakazu Fukuda; Minoru Nakano; Masakazu Miyazaki; Masafumi Tanaka; Hiroyuki Saito; Satoe Kobayashi; Masaharu Ueno; Tetsurou Handa
Journal:  J Lipid Res       Date:  2008-07-21       Impact factor: 5.922

10.  PI(4,5)P2 Is Translocated by ABCA1 to the Cell Surface Where It Mediates Apolipoprotein A1 Binding and Nascent HDL Assembly.

Authors:  Kailash Gulshan; Gregory Brubaker; Heather Conger; Shuhui Wang; Renliang Zhang; Stanley L Hazen; Jonathan D Smith
Journal:  Circ Res       Date:  2016-08-11       Impact factor: 17.367

View more
  5 in total

Review 1.  Molecular mechanisms for ABCA1-mediated cholesterol efflux.

Authors:  Lei Chen; Zhen-Wang Zhao; Peng-Hui Zeng; Ying-Jie Zhou; Wen-Jun Yin
Journal:  Cell Cycle       Date:  2022-02-22       Impact factor: 5.173

Review 2.  Annual Report on Sex in Preclinical Studies: Arteriosclerosis, Thrombosis, and Vascular Biology Publications in 2018.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-23       Impact factor: 8.311

3.  Hyperlipidaemia and IFNgamma/TNFalpha Synergism are associated with cholesterol crystal formation in Endothelial cells partly through modulation of Lysosomal pH and Cholesterol homeostasis.

Authors:  Yvonne Baumer; Amit K Dey; Cristhian A Gutierrez-Huerta; Noor O Khalil; Yusuke Sekine; Gregory E Sanda; Jie Zhuang; Ankit Saxena; Erin Stempinski; Youssef A Elnabawi; Pradeep K Dagur; Qimin Ng; Heather L Teague; Andrew Keel; Justin A Rodante; William A Boisvert; Lam C Tsoi; Johann E Gudjonsson; Christopher K E Bleck; Marcus Y Chen; David A Bluemke; Joel M Gelfand; Daniella M Schwartz; Howard S Kruth; Tiffany M Powell-Wiley; Martin P Playford; Nehal N Mehta
Journal:  EBioMedicine       Date:  2020-07-06       Impact factor: 8.143

4.  (Pro)renin Receptor Inhibition Reduces Plasma Cholesterol and Triglycerides but Does Not Attenuate Atherosclerosis in Atherosclerotic Mice.

Authors:  Dien Ye; Xiaofei Yang; Liwei Ren; Hong S Lu; Yuan Sun; Hui Lin; Lunbo Tan; Na Wang; Genevieve Nguyen; Michael Bader; Adam E Mullick; A H Jan Danser; Alan Daugherty; Yizhou Jiang; Yidan Sun; Furong Li; Xifeng Lu
Journal:  Front Cardiovasc Med       Date:  2021-12-24

5.  PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer.

Authors:  Amrita Salvi; Alexandria N Young; Andrew C Huntsman; Melissa R Pergande; Melissa A Korkmaz; Rathnayake A Rathnayake; Brittney K Mize; A Douglas Kinghorn; Xiaoli Zhang; Kiira Ratia; Markus Schirle; Jason R Thomas; Scott M Brittain; Claude Shelton; Leslie N Aldrich; Stephanie M Cologna; James R Fuchs; Joanna E Burdette
Journal:  Cell Death Dis       Date:  2022-01-10       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.